🇺🇸 FDA
Pipeline program

REOLYSIN

REO 018

Phase 3 mab completed

Quick answer

REOLYSIN for Carcinoma, Squamous Cell of the Head and Neck is a Phase 3 program (mab) at ONCOLYTICS BIOTECH INC with 2 ClinicalTrials.gov record(s).

Program details

Company
ONCOLYTICS BIOTECH INC
Indication
Carcinoma, Squamous Cell of the Head and Neck
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials